Dendreon is committed to supporting men with advanced prostate cancer.
You can get the PROVENGE conversation started by accessing questions to ask your urologist or oncologist.
PROVENGE is covered by Medicare and most commercial plans, and there are several programs for patients who need financial and access support. Use the doctor locator to find a urologist or oncologist near you.
Prostate cancer is the most common cancer among men in America, after skin cancer. The American Cancer Society estimates that more than 160,000 men in the United States will be diagnosed with prostate cancer in 2018 alone. There are many ways to connect with a large community of men undergoing a similar journey to yours. Connect with support resources for your prostate cancer fight.
You know PROVENGE is different from other treatment options for advanced prostate cancer. Explore the steps in your PROVENGE treatment experience.
You have questions and Dendreon has answers. Browse the FAQs to learn more about advanced prostate cancer, immunotherapy, and PROVENGE.
The first and only personalized immunotherapy for mCRPC.
PROVENGE® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information.
Access this brochure to learn about PROVENGE and how it may help certain men with advanced prostate cancer (mCRPC) live longer.